First Trust Advisors LP Blueprint Medicines Corp Transaction History

First Trust Advisors LP

$101 Billion
Q3 2024

A detailed history of First Trust Advisors LP transactions in Blueprint Medicines Corp stock. As of the latest transaction made, First Trust Advisors LP holds 54,828 shares of BPMC stock, worth $4.96 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

54,828

Previous 60,138 8.83%

Holding current value

$4.96 Million

Previous $6.48 Million 21.79%

% of portfolio

0.01%

Previous 0.01%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$84.1 - $120.5 $446,570 - $639,855	-5,310 Reduced 8.83%	54,828 $5.07 Million
Q2 2024 Aug 13, 2024	BUY	$85.18 - $108.78 $1.1 Million - $1.4 Million	12,867 Added 27.22%	60,138 $6.48 Million
Q1 2024 May 13, 2024	BUY	$73.17 - $99.79 $3.46 Million - $4.72 Million	47,271 New	47,271 $4.48 Million
Q4 2022 Feb 09, 2023	BUY	$41.06 - $66.48 $999,112 - $1.62 Million	24,333 Added 334.98%	31,597 $1.38 Million
Q3 2022 Nov 14, 2022	SELL	$49.93 - $77.7 $183,942 - $286,246	-3,684 Reduced 33.65%	7,264 $479,000
Q2 2022 Aug 12, 2022	BUY	$45.23 - $70.15 $38,083 - $59,066	842 Added 8.33%	10,948 $553,000
Q1 2022 May 13, 2022	SELL	$54.1 - $110.08 $2.38 Million - $4.84 Million	-44,007 Reduced 81.32%	10,106 $646,000
Q4 2021 Feb 08, 2022	BUY	$94.25 - $115.99 $3.89 Million - $4.79 Million	41,306 Added 322.53%	54,113 $5.8 Million
Q3 2021 Nov 15, 2021	SELL	$80.98 - $109.47 $921,795 - $1.25 Million	-11,383 Reduced 47.06%	12,807 $1.32 Million
Q2 2021 Aug 16, 2021	SELL	$82.78 - $101.0 $2.36 Million - $2.88 Million	-28,544 Reduced 54.13%	24,190 $2.13 Million
Q1 2021 May 14, 2021	BUY	$90.71 - $108.28 $207,363 - $247,528	2,286 Added 4.53%	52,734 $5.13 Million
Q4 2020 Feb 02, 2021	BUY	$92.08 - $124.48 $2.09 Million - $2.82 Million	22,646 Added 81.45%	50,448 $5.66 Million
Q3 2020 Nov 05, 2020	BUY	$66.45 - $92.7 $826,571 - $1.15 Million	12,439 Added 80.97%	27,802 $2.58 Million
Q2 2020 Jul 22, 2020	BUY	$57.09 - $79.27 $877,073 - $1.22 Million	15,363 New	15,363 $1.2 Million
Q4 2019 Feb 03, 2020	SELL	$66.73 - $82.59 $4.18 Million - $5.18 Million	-62,690 Closed	0 $0
Q3 2019 Nov 04, 2019	BUY	$72.9 - $101.41 $1.46 Million - $2.03 Million	20,042 Added 46.99%	62,690 $4.61 Million
Q2 2019 Jul 30, 2019	BUY	$73.54 - $97.8 $2.08 Million - $2.77 Million	28,349 Added 198.26%	42,648 $4.02 Million
Q1 2019 May 09, 2019	SELL	$48.7 - $86.6 $559,173 - $994,341	-11,482 Reduced 44.54%	14,299 $1.15 Million
Q4 2018 Feb 07, 2019	BUY	$45.57 - $74.26 $1.17 Million - $1.91 Million	25,781 New	25,781 $1.39 Million
Q3 2018 Oct 25, 2018	SELL	$58.91 - $78.32 $1.46 Million - $1.93 Million	-24,702 Closed	0 $0
Q2 2018 Aug 02, 2018	SELL	$60.96 - $101.18 $2.22 Million - $3.69 Million	-36,483 Reduced 59.63%	24,702 $1.57 Million
Q1 2018 Apr 23, 2018	BUY	$73.28 - $102.95 $2.44 Million - $3.43 Million	33,276 Added 119.23%	61,185 $5.61 Million
Q4 2017 Feb 08, 2018	SELL	$62.91 - $88.32 $1.26 Million - $1.77 Million	-20,046 Reduced 41.8%	27,909 $2.11 Million
Q3 2017 Oct 24, 2017	BUY	$42.37 - $69.67 $2.03 Million - $3.34 Million	47,955	47,955 $3.34 Million

Others Institutions Holding BPMC

# of Institutions

351

Shares Held

60.3M

Call Options Held

2.25M

Put Options Held

1.18M

View Full List

About Blueprint Medicines Corp

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $5.4B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

More about BPMC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.

Account

First Trust Advisors LP Blueprint Medicines Corp Transaction History